STING1 and neoplasm: However, STING activation can also promote tumor growth (161), metastasis (162) and enhance autoimmune diseases (51), suggesting that immunotherapies need to achieve a correct balance between stimulating an antitumor response and avoiding tumor-promoting inflammation.